Acquiring Company
Transpharmation Ltd
Acquired Company
OrganoTherapeutics SARL
Toronto
LuxembourgBiotechnologyHealth CareBiotechnologyHealth CareDescription
Transpharmation Ltd. has announced its acquisition of OrganoTherapeutics SARL, a leader in patient-derived organoid technologies for neurodegenerative and CNS disorders. OrganoTherapeutics will continue to operate as a subsidiary of Transpharmation. The deal combines Transpharmation's in vivo pharmacology expertise with organoid models to offer clients both approaches.
Who to call at Transpharmation Ltd, and when
When Transpharmation Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Transpharmation Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Transpharmation Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Transpharmation Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Transpharmation Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired OrganoTherapeutics SARL?
OrganoTherapeutics SARL was acquired by Transpharmation Ltd, based in Toronto. The deal was reported on October 28, 2026. Transpharmation Ltd. is a science-led global leader in neuroscience, pain and metabolic disease preclinical contract research. Transpharmation Ltd is privately held and operates in Biotechnology.
When did Transpharmation Ltd acquire OrganoTherapeutics SARL?
Transpharmation Ltd's acquisition of OrganoTherapeutics SARL was reported on October 28, 2026. Transpharmation Ltd. has announced its acquisition of OrganoTherapeutics SARL, a leader in patient-derived organoid technologies for neurodegenerative and CNS disorders. OrganoTherapeutics will continue to operate as a subsidiary of Transpharmation. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does OrganoTherapeutics SARL do?
OrganoTherapeutics SARL is a leader in patient-derived organoid technologies for neurodegenerative and CNS disorders. It is privately held, operating in Biotechnology, and is based in Luxembourg.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.